SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Headlines > Upstream Processing

Read more breaking news

 

 
BPI Europe 2016

Pall: Bioprocessing's future is made of virtual reality

Dan Stanton

By Dan Stanton+

27-Apr-2016
Last updated on 27-Apr-2016 at 13:54 GMT2016-04-27T13:54:10Z

Pall is using the HakoBio virtual reality platform. Image courtesy of Ouat!

Pall is using the HakoBio virtual reality platform. Image courtesy of Ouat!

Pall Corporation has embraced a virtual reality platform to showcase some of its bioprocessing systems at industry shows.

HakoBio is a virtual reality platform developed by life science marketing firm OUAT! alonside Pall Corporation to provide the biomanufacturing industry with a tool to help configure, visualise and feel processes & lab rooms.

The supplier of filtration, separations and purification products unveiled the platform at Bioprocess International Europe earlier this month in order to showcase its portfolio without the logistical burden of carrying and setting up equipment in Vienna, Austria, and is set to do the same at Interphex in New York City this week.

Wolfgang Weinkum, marketing manager at Pall said the platform allows drugmakers to plan their own facility - much like Ikea's online planning tool , albeit for upstream and downstream equipment rather than flat-pack kitchen units - and then visualise the plant through the use of the virtual reality headset.

This luddite of a journalist was sceptical but picked up the equipment to try it himself and was instantly converted, though whether this is the future of marketing or an addictive gimmick remains to be seen.

Either way, the platform is now available to other players from the bioprocess/bioproducution world, a spokesman from OUAT! told this publication. 

Pall's shake-up of its portfolio showcasing came a year after rival firm GE Healthcare displayed its offerings using Xbox Kinect sensor technology which Biopharma-Reporter captured on slightly less impressive technology at BPI Europe 2015.

Related products

Continuous chromatography and single-use filtration at BPI Europe

Continuous chromatography and single-use filtration at BPI Europe

Pall Corporation, GE Healthcare and LEWA Process Technologies showed off their latest downstream offerings...

Getting a feel for bioprocessing at the Biotech Training Facility

Getting a feel for biomanufacturing at the Biotech Training Facility

Ronald Kompier

Managing Director, Biotech Training Facility

Pall: Bioprocessing's future is made of virtual reality

Pall: Bioprocessing's future is made of virtual reality

Pall Corporation has embraced a virtual reality platform to showcase some of its bioprocessing...

BioFinance Vision: Are Pfizer and Novartis in the biosimilar saddle?

BioFinance Vision: Are Pfizer and Novartis in the biosimilar saddle?

With Pfizer closing in on Hospira and Sandoz set to launch Zarxio in the...

Bio-Finance Vision... Baxalta, Pall and more in glorious technicolour

Bio-Finance Vision... Baxalta, Pall and more in glorious technicolour

We say hello to Baxalta, ask what's the latest in Danaher's $14bn bid for...

Virtual Sterility? GE uses Xbox tech to showcase products

Virtual Sterility? GE uses Xbox tech to showcase products

Janine de la Fuente

Event specialist , GE Healthcare

William Reed Business Media Holiday video

Happy Holidays 2014 from William Reed Business Media!

The holidays are fast upon us, so let’s put ‘business’ to one side and...

Catalent commits to ADCs by upping its stake in Redwood

Catalent commits to ADCs by upping its stake in Redwood

Aileen Ruff

Global Strategic Marketing Director, Biologics and Sterile Technologies at Catalent...

So far, so very good: Pall and ATMI talk integration at interphex

So far, so very good: Pall and ATMI talk integration at interphex

Ken Frank & Mario Philips

Pall Corporation

To QbD or not to QbD? For biologics it's a must says Cook Pharmica expert

To QbD or not to QbD? For biologics it's a must says Cook Pharmica expert

Kumar Dhanasekharan

Senior Leader in Biologics Process Development and Innovation, Cook Pharmica

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

Piramal’s COO Vijay Shah described antibody-drug conjugates (ADCs) as “a concept whose time has come” at...

Better single-use cross flow techs still needed says GE Healthcare

Better single-use cross flow techs still needed says GE Healthcare

Neil Ross

Marketing Manager - Bioprocess EMEA, Life Sciences, GE Healthcare

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

The single-use age has dawned, says ThermoFisher

The single-use age has dawned, says ThermoFisher

Bill Whitford

Senior manager of the bioprocessing market , ThermoFisher

European CMO market will double in just 6 years, says Frost & Sullivan

European CMO market will double in just 6 years, says Frost & Sullivan

Aiswariya Chidambaram

Healthcare market analyst, Frost & Sullivan

Unilife launches Autoinfuser range publically

Unilife launches Autoinfuser range publically

Stephen Allan

VP of marketing and communications , Unilife

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...